Home |  Site Map |  Inquire Now |  Shuangweibio
 
Clinical Efficacy of Phase Leukocyte Reduction Filters in High-risk Patients (1)
Home > News > Industry News > Clinical Efficacy of Phase Leukocyte Reduction Filters in High-risk Patients (1)

Clinical Efficacy of Phase Leukocyte Reduction Filters in High-risk Patients (1)


The purpose of this study was to investigate the clinical outcome, inflammatory response and myocardial function in high-risk patients undergoing three different leukocyte reduction filters depletion strategies. Over a four-month period, forty patients undergoing coronary revascularization were prospectively randomized to one of the four perfusion protocols. Conventional circuits two leukocyte filters with the method of two-phase leukofiltration; single leukocyte reduction filters with the method of continuous leukofiltration leukocyte filter with the method of strategic leukofiltration. Control without leukocyte filtration. Blood samples were collected at Baseline. Perioperative follow-up was thoroughly monitored.

back

What's New
Multi Color Orthopaedic Fiberglass Casting Tapes
Our Business
Contact Us
Tel: 86-25-58847598
                 58745027
Fax: 86-25-58745107
Email:njswbio@gmail.com
Product Categories
armor-wrap chinese coal buyers coal buyer coal importer Leukocyte Reduction Filters Orthopedic Casting Tapes Resources steam coal buyer thermal coal buyers | Friendly Links
Certificates | Contact Us | Privacy Policy | Rice Mill Plant | Sitemap
Shuangwei Biotechnology Co., Ltd. All Rights Reserved